Cipla share price
You have to be logged in to add this to Watchlist.- ₹1,461.60(0.53%)March 13, 2025 15:40:47 PM IST
- NSE
- BSE
- Vol : 815.38K (NSE + BSE)Last 20 day avg : 1.42 M
Cipla is trading 0.53% upper at Rs 1,461.60 as compared to its last closing price. Cipla has been trading in the price range of 1,465.00 & 1,447.35. Cipla has given -4.39% in this year & 0.01% in the last 5 days. Cipla has TTM P/E ratio 24.74 as compared to the sector P/E of 28.29.There are 32 analysts who have initiated coverage on Cipla. There are 7 analysts who have given it a strong buy rating & 12 analysts have given it a buy rating. 4 analysts have given the stock a sell rating.The company posted a net profit of 1,570.51 Crores in its last quarter.Listed peers of Cipla include Sun Pharmaceutical Industries (0.45%), Divis Laboratories (-0.95%), Cipla (0.53%).The Mutual Fund holding in Cipla was at 20.46% in 31 Dec 2024. The MF holding has increased from the last quarter. The FII holding in Cipla was at 26.65% in 31 Dec 2024. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on Mar 16, 2025, 08:35 PM UTC
- Dividend YieldLower than industry0.89Annual dividends as a percentage of the stock price.
- P/BLower than historical values4.42The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values23.67Price-to-earnings ratio based on trailing 12-month earnings
- BetaLow volatility0.71Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.02The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable- The company's revenue grew in December quarter by 7.10% from Rs 7072.97 crore to Rs 6603.81 crore, year-on-year
- The company has grown its December quarter profit by 48.74% from Rs 1055.90 crore to Rs 1570.51 crore, year-on-year
The debt to equity of the company is higher than the industry median- Company can comfortably pay off its interest obligations with its earnings
- R1
- 1,466.03
- R2
- 1,521.12
- R3
- 1,559.13
- S1
- 1,372.93
- S2
- 1,334.92
- S3
- 1,279.83
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Neutral | 1,683.85 | 0.45 | 4,04,002.15 | 40.34 | 6.34 | 0.92 | 0.48 |
| Divis Laboratories | Neutral | 5,611.60 | -0.95 | 1,48,903.05 | 93.08 | 10.99 | 0.53 | 0.01 |
| Cipla | Neutral | 1,461.60 | 0.53 | 1,18,040.87 | 27.19 | 4.42 | 0.89 | 0.84 |
| Torrent Pharmaceuticals | Neutral | 3,062.30 | -1.10 | 1,03,637.50 | 64.51 | 15.09 | 1.05 | 24.33 |
| Dr Reddys Laboratories | Bearish | 1,107.85 | 0.24 | 92,439.57 | 16.77 | 3.27 | 0.72 | 2.12 |
- Promoter(s) does not have a high stake in the company
- Promoter(s) have decreased the stake in the company in last 12 months
- FIIs are invested in this company
- FIIs holding has decreased by 2.15 percentage points from previous quarter
- Mutual Funds holding has increased by 2.98 percentage points from previous quarter
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-01-28 | Quarterly Results |
| 2024-10-29 | Quarterly Results |
| 2024-07-26 | Quarterly Results |
| 2024-05-10 | Audited Results & Final Dividend |
| 2024-01-25 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE059A01026
- BSE Code500087
- NSE CodeCIPLA
Cipla is trading at 1461.60 as on Thu Mar 13 2025 10:10:47. This is 0.53% upper as compared to its previous closing price of 1453.85.
The market capitalization of Cipla is 118040.87 Cr as on Thu Mar 13 2025 10:10:47.
The average broker rating on Cipla is Buy. The breakup of analyst rating is given below -
- 7 analysts have given a strong buy rating
- 12 analysts have given a buy rating
- 8 analysts have given a hold rating
- 4 analysts have given a sell rating
- 1 analysts have given a strong sell rating
The 52 wk high for Cipla is 1702.00 whereas the 52 wk low is 1317.60
Cipla can be analyzed on the following key metrics -
- TTM P/E: 24.74
- Sector P/E: 28.29
- Dividend Yield: 0.89%
- D/E ratio: -
Cipla reported a net profit of 4121.55 Cr in 2024.
The Mutual Fund Shareholding was 20.46% at the end of 31 Dec 2024.